Article Details
Retrieved on: 2021-07-23 14:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A low dose of capivasertib, by contrast, inhibited tumor growth by 50% in both models, the researchers reported. RELATED: ESMO: Roche's Akt inhibitor ...
Article found on: www.fiercebiotech.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here